Rituximab Induces Effective Clearance of Minimal Residual Disease in Molecular Relapses of Mantle Cell Lymphoma
Open Access
- 1 December 2006
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 12 (12), 1270-1276
- https://doi.org/10.1016/j.bbmt.2006.07.007
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Current Treatment Approaches for Mantle-Cell LymphomaJournal of Clinical Oncology, 2005
- Hematopoietic stem cell transplantation in mantle cell lymphomaAnnals of Oncology, 2005
- Immunochemotherapy With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Significantly Improves Response and Time to Treatment Failure, But Not Long-Term Outcome in Patients With Previously Untreated Mantle Cell Lymphoma: Results of a Prospective Randomized Trial of the German Low Grade Lymphoma Study Group (GLSG)Journal of Clinical Oncology, 2005
- Clearing Minimal Residual Disease with Rituximab Consolidation TherapySeminars in Oncology, 2004
- Mantle cell lymphoma: established therapeutic options and future directionsAnnals of Hematology, 2004
- Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: evidence for a role of both chemotherapy and rituximab infusionBlood, 2000
- The effect of Rituximab on patients with follicular and mantle-cell lymphomaAnnals of Oncology, 2000
- European Phase II Study of Rituximab (Chimeric Anti-CD20 Monoclonal Antibody) for Patients With Newly Diagnosed Mantle-Cell Lymphoma and Previously Treated Mantle-Cell Lymphoma, Immunocytoma, and Small B-Cell Lymphocytic LymphomaJournal of Clinical Oncology, 2000
- High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission.Journal of Clinical Oncology, 1998
- Molecular Monitoring of Minimal Residual Disease in Follicular and Mantle Cell Non-Hodgkin's Lymphomas Treated With High-Dose Chemotherapy and Peripheral Blood Progenitor Cell AutograftingBlood, 1997